PYROSEQUENCING

PYROSEQUENCING CHANGES NAME TO BIOTAGE

Thu, Dec 04, 2003 09:00 CET

PYROSEQUENCING CHANGES NAME TO BIOTAGE Uppsala Sweden, December 4, 2003 - Pyrosequencing AB (Stockholm: PYRO A) announces that the extraordinary shareholders' meeting on December 3, 2003 decided, in accordance with the Board's proposal, that Pyrosequencing AB will change its name to Biotage AB. The reason for the name change is that Pyrosequencing is the name of the technology that the Company originally built its operations on. The new name Biotage will instead represent the new company, which has been built during the fall 2003. In the new company, systems for genomic analysis coexist

NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

Mon, Nov 03, 2003 09:47 CET

NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS The Shareholders of Pyrosequencing AB (publ), Reg. No. 556539-3138, are hereby summoned to an extraordinary general meeting of shareholders to be held on Wednesday 3 December 2003, at 5 pm at Mannheimer Swartling Advokatbyrå AB, Norrmalmstorg 4 in Stockholm, Sweden. Notice etc Shareholders that wish to participate in the general meeting of shareholders shall a) be listed in the register of shareholders held by VPC AB as of Friday 21 November 2003 and b) notify their intention to participate in the meeting not later than Friday 28

Pyrosequencing finalizes acquisition of Biotage

Thu, Oct 30, 2003 10:45 CET

PYROSEQUENCING FINALIZES ACQUISITION OF BIOTAGE Uppsala, Sweden October 30, 2003 - Pyrosequencing AB (Stockholm: PYROA) today announced that the Company has finalized the acquisition of Biotage, as announced on October 14, through a cash payment of 235 MSEK and taking over a mortgage of 36 MSEK, relating to the premises in Virginia US. Pyrosequencing now owns 100 percent of the shares in Biotage. Pyrosequencing now has a turnover of 427 MSEK, pro forma 2002. Biotage combined with Personal Chemistry, which was acquired earlier this year, forms business area Discovery Chemistry. This business

New management and new name for Pyrosequencing

Thu, Oct 23, 2003 15:15 CET

NEW MANAGEMENT AND NEW NAME FOR PYROSEQUENCING Uppsala, Sweden, October 23, 2003 - Pyrosequencing AB (Stockholm: PYRO A) announces that in connection with the acquisition of Biotage the Company will get a new organization and a new management team. The Board also proposes that Pyrosequencing will change its name to Biotage, but will keep the logotype used since the start of the company. The name change is conditional upon the approval from an extra shareholder's meeting. The Company will call for an extra shareholders' meeting shortly. The corporate group gets a new name, but the company's

Decision on new share issue

Thu, Oct 23, 2003 14:42 CET

DECISION ON NEW SHARE ISSUE Uppsala, Sweden, October 23, 2003 - Pyrosequencing AB ("Pyrosequencing") (Stockholm: PYRO A) announces that the Board of Pyrosequencing today decided on, based on the authorization from the extraordinary general meeting on September 25, 2003, a non-cash issue of a maximum of 56,613 ordinary shares and an issue of debentures together with a maximum of 52,238 warrants for subscription of a maximum of 52,238 new ordinary shares in the Company. The issues are made due to acquisitions of additional shares in Personal Chemistry in Uppsala AB ("Personal Chemistry").

Interim report Jan - Sept Pyrosequencing

Thu, Oct 23, 2003 14:30 CET

Interim report January - September 2003 Uppsala, Sweden, October 23, 2003. Pyrosequencing AB (Stockholm: PYRO A) today reported results for the first nine months 2003. Highlights (Figures in brackets refer to the same period 2002) - Sales during the period amounted to 68.6 MSEK (63.4 MSEK) - Operating result excluding non-recurring items for the period was - 116.7 MSEK (-117.4 MSEK) - Result after tax was -189.6 MSEK (-120.6 MSEK) for the period - Earnings per share amounted to - 5.44 SEK (-3.47 SEK) for the period - The acquisition of Personal Chemistry was approved by an extraordinary

PYROSEQUENCING ACQUIRES US BIOTAGE

Tue, Oct 14, 2003 15:51 CET

PYROSEQUENCING ACQUIRES US BIOTAGE Uppsala Sweden 14 October 2003 - Pyrosequencing AB (Stockholm PYROA) announces that the Company has entered into an agreement with Dyax Corp. ("Dyax") to acquire Biotage LLC ("Biotage"), a wholly-owned subsidiary of Dyax for approximately $ 35 million in cash. The Company plans to take over mortgage on Biotage's newly built premises in Virginia, which will reduce the purchase price to approximately $ 30 million. Through the acquisition, the product line Medicinal Chemistry will be strengthened with a supplementary product portfolio of purification and

Two orders of scale-up technology to Pyrosequencing

Mon, Oct 13, 2003 09:31 CET

TWO ORDERS OF SCALE-UP TECHNOLOGY TO PYROSEQUENCING Uppsala, Sweden, October 13, 2003 - Pyrosequencing AB (Stockholm: PYRO A) announces that two independent major pharmaceutical companies have each placed one order for microwave scale-up technology. The total value of the orders is over SEK 5,000,000. "We have succeeded in helping pharmaceutical companies to rapidly progress their drug research projects into advanced development stages, hence the need for scale-up solutions," said President and COO of Pyrosequencing, Hans Johansson "This is an important milestone and a strong evidence of

Pyrosequencing implements new organization

Mon, Sep 29, 2003 12:30 CET

PYROSEQUENCING IMPLEMENTS NEW ORGANIZATION Uppsala, Sweden September 29, 2003 - Pyrosequencing AB (Stockholm: PYRO A) today announced that, following the approval of the extraordinary shareholders' meeting of the acquisition of Personal Chemistry, the company will now start to implement a cost-savings program that is expected to generate annual cost synergies in the order of SEK 45-55 million. The first step is a new corporate structure, effective from October 1 when Hans Johansson starts as President, and a proposal of staff reduction of approximately 30 people out of which approximately

Extraordinary general meeting in Pyrosequencing AB

Fri, Sep 26, 2003 08:30 CET

EXTRAORDINARY GENERAL MEETING IN PYROSEQUENCING AB Uppsala, Sweden, September 26, 2003 - Pyrosequencing AB (Stockholm: PYROA) announces that the extraordinary general meeting of shareholders in Pyrosequencing AB ("Pyrosequencing") held on September 25, 2003, in accordance with previously announced proposals, adopted resolutions to issue new shares and debentures together with warrants. This will make possible the payment to shareholders in Personal Chemistry i Uppsala AB ("Personal Chemistry") in connection with Pyrosequencing's acquisition of Personal Chemistry. Pyrosequencing's share

New President and Management Team at Pyrosequencing

Wed, Aug 27, 2003 15:30 CET

NEW PRESIDENT AND MANAGEMENT TEAM AT PYROSEQUENCING Uppsala, August 27, 2003 - Pyrosequencing AB (Stockholm: PYRO A) today announced the appointment of the new management team for the new Company in connection with the completion of the merger with Personal Chemistry in Uppsala AB, "Personal Chemistry". The merger is planned to take place after the extraordinary general meeting on September 25, 2003. Jeff Bork continues as Chairman of the Board and CEO. Hans Johansson, currently President of Personal Chemistry, becomes the new President and COO, Mats- Olof Wallin continues as CFO and Mårten

Extraordinary General Meeting in Pyrosequencing

Fri, Aug 22, 2003 15:25 CET

Extraordinary General Meeting in Pyrosequencing Regarding the Acquisition of Personal Chemistry Uppsala, Sweden, August 22, 2003 As announced on August 7, 2003, Pyrosequencing AB ("Pyrosequencing") (Stockholm: PYRO A) and the principal shareholders in Personal Chemistry in Uppsala AB ("Personal Chemistry") have reached an agreement that Pyrosequencing will acquire the principal shareholders' shares in Personal Chemistry, representing 94.1 percent of the share capital and votes in the company. As a consequence of this, Pyrosequencing's Board has today decided to call for an extraordinary

454 Life Sciences obtains license from Pyrosequencing

Tue, Aug 19, 2003 13:30 CET

454 Life Sciences Obtains Exclusive License from Pyrosequencing AB to Next Generation Sequencing Technology for Whole Genome Applications Branford, CT and Uppsala, Sweden - August 19, 2003 - 454 Life Sciences, an innovative developer of genome-scale sequencing technologies and a majority-owned subsidiary of CuraGen Corporation (NASDAQ: CRGN), today announced that the Company has obtained an exclusive license for sole use of sequencing by synthesis and pyrophosphate based sequencing for whole genome applications from Pyrosequencing AB (Stockholm: PYRO A), a global technology solutions

Pyrosequencing Acquires Personal Chemistry

Thu, Aug 07, 2003 16:28 CET

Pyrosequencing Acquires Personal Chemistry · Pyrosequencing acquires Personal Chemistry through a directed issue · 94.1% of Personal Chemistry's shareholders support the transaction · The acquisition of Personal Chemistry creates critical mass, gives a broader product portfolio and platform for continued consolidation · Doubled sales and substantial cost synergies within administration and marketing improves possibility to reach profitability quicker Pyrosequencing AB ("Pyrosequencing") and the principal shareholders in Personal Chemistry i Uppsala AB ("Personal Chemistry") have reached an

Pyrosequencing AB Reports Half-Year Results for Period Ended June 30, 2003

Thu, Aug 07, 2003 16:00 CET

Pyrosequencing AB Reports Half-Year Results for Period Ended June 30, 2003 Pyrosequencing acquires Personal Chemistry AB (see separate press release) Jeff Bork, Chairman of the Board, appointed new CEO New cost-savings program in Pyrosequencing Uppsala, Sweden, August 7, 2003. Pyrosequencing AB (Stockholm: PYRO A) today reported results for the first six months and the second quarter 2003. Erik Walldén, President of Pyrosequencing, said: "During the first six months sales increased by 13 percent compared to the same period last year. Excluding currency effects, the increase was 30 percent.

Update from Pyrosequencing´s Annual General Meeting

Thu, Apr 24, 2003 19:47 CET

UPDATE FROM PYROSEQUENCING'S ANNUAL GENERAL MEETING Uppsala, Sweden, April 24, 2003 - Pyrosequencing AB (Stockholm: PYRO A) announced that the following decisions were made at the Shareholder's Annual General Meeting held today. The Board members Lars Gatenbeck, Björn Odlander, Mathias Uhlén, Bengt Samuelsson and Eugen Steiner were re-elected for another term. Jeff Bork was elected as a new member. The board has announced that they intend to appoint Jeff Bork as Chairman of the Board. In addition, it was decided that total Board compensation would be SEK 1,170,000, to be divided among the

Pyrosequencing AB Reports First Quarter Results for Period Ended March 31, 2003

Thu, Apr 24, 2003 16:04 CET

Pyrosequencing AB Reports First Quarter Results for Period Ended March 31, 2003 - New systems contribute to healthy sales growth and cost-savings program reduces expenses - Uppsala, Sweden, April 24, 2003, Pyrosequencing AB (Stockholm: PYRO A) today reported first quarter results for the period ended March 31, 2003. Erik Walldén, President and CEO of Pyrosequencing, commented: "I am satisfied with the strong start to this year. In the first quarter, sales increased by 21 percent compared to the same period last year. Excluding currency effects, the increase was 40 percent. This is clear

Proposal for members of the board of directors of Pyrosequencing AB

Thu, Apr 17, 2003 17:55 CET

PROPOSAL FOR MEMBERS OF THE BOARD OF DIRECTORS OF PYROSEQUENCING AB Uppsala, Sweden, April 17, 2003 - The Annual General Meeting of Pyrosequencing AB (Stockholm: PYRO A) will be held on Thursday, April 24, 2003 at 5:00 p.m. (local time) at Radisson SAS Hotel Gillet, Dragarbrunnsgatan 26, Uppsala, Sweden. Pyrosequencing AB has been informed that the Nomination Committee intends to present the following proposal, which is supported by shareholders representing 31.2 percent of the shares. The proposed number of board members is 6. Remuneration to the Board of Directors is proposed to amount to

Pyrosequencing expands corbett distribution agreement to Germany, France and Scandinavia

Thu, Apr 10, 2003 15:00 CET

PYROSEQUENCING EXPANDS CORBETT DISTRIBUTION AGREEMENT TO GERMANY, FRANCE AND SCANDINAVIA Uppsala, Sweden, April 10, 2003 - Pyrosequencing AB (Stockholm: PYRO A) today announced that the Company has extended its distribution for Corbett Research's full line of thermocycling and sample preparation products to cover Germany, France and Scandinavia. Pyrosequencing now offers customers a more comprehensive portfolio of tools for applied genetic analysis from DNA preparation and amplification through sequence analysis. The geographic expansion enables Pyrosequencing's direct sales and support

Pyrosequencing Extends Vacuum Prep Tool Capabilities And Introduces New Accompanying Workstation

Wed, Feb 26, 2003 15:00 CET

PYROSEQUENCING EXTENDS VACUUM PREP TOOL CAPABILITIES AND INTRODUCES NEW ACCOMPANYING WORKSTATION Uppsala, Sweden, February 26, 2003 - Pyrosequencing AB (Stockholm: PYRO A) today announced that the acclaimed Pyrosequencing(TM) Vacuum Prep Tool is now available for all 96-well format Pyrosequencing genetic analysis systems - extending the benefits of batch processing 96 post- PCR samples in less than 15 minutes to PSQ(TM)96MA and PSQ(TM)96 System customers. The Vacuum Prep Tool is also more cost effective due to doubling the life of the 96 filter probes within the hand-held device. Sample

Pyrosequencing AB Reports Fourth Quarter and Year End Results for Period Ended December 31, 2002

Thu, Feb 20, 2003 14:26 CET

Pyrosequencing AB Reports Fourth Quarter and Year End Results for Period Ended December 31, 2002 -- Expansion of product offering, marketing capability and IP as Company implements expense reduction -- Uppsala, Sweden, February 20, 2003, Pyrosequencing AB (Stockholm: PYRO A) today reported fourth quarter and year-end results for the period ended December 31, 2002. Erik Walldén, President and CEO of Pyrosequencing, commented: "Pyrosequencing made important progress in 2002 against a background of tough market conditions. We expanded our product offering, strengthened the intellectual

Pyrosequencing to distribute corbett products in the u.s.

Tue, Jan 14, 2003 14:00 CET

PYROSEQUENCING TO DISTRIBUTE CORBETT PRODUCTS IN THE U.S. - Company to make equity investment in Bio-Molecular Holdings - Uppsala, January 14, 2003 - Pyrosequencing AB (Stockholm: PYRO A) today reported that the Company signed an agreement to distribute Corbett Research's full line of thermocycling and sample preparation products in the United States. Pyrosequencing and Corbett believe that their complementary product lines and sales processes will offer customers a more comprehensive portfolio of tools for applied genetic analysis. As part of the agreement, Pyrosequencing will make an

Financial reports from Pyrosequencing AB

Wed, Jan 08, 2003 14:45 CET

FINANCIAL REPORTS FROM PYROSEQUENCING AB Uppsala, Sweden, January 8, 2003 -- Pyrosequencing AB (Stockholm: PYRO A) will publish the following financial reports: Year-end Report, 2002 February 20, 2003 Interim Report January - March, 2003 April 24, 2003 Interim Report January - June, 2003 August 7, 2003 Interim Report January - September, 2003 October 23, 2003 The Annual General Meeting will be held on April 24, 2003 Pyrosequencing AB Erik Walldén President and CEO ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.